Although the results of the present study suggest direct immunomodulatory effects of DPPIV inhibition on T1D, a contribution of incretin modification or other additional factors that were not evaluated cannot completely be ruled out. The gene discussed is DPP4; the disease is type 1 diabetes mellitus.